PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

Clinical trial NCT07454915 · RECRUITING

Trial details

NCT number: NCT07454915
Sponsor: PapiVax Biotech, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Intraepithelial Neoplasia Grade 2/3 Human Papilloma Virus Infection Type 16

Start date: 2026-04-01
Primary completion: 2027-12-01
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.